X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gadoterate meglumine (59) 59
index medicus (55) 55
radiology, nuclear medicine & medical imaging (51) 51
humans (46) 46
gadolinium (36) 36
female (35) 35
male (34) 34
nephrogenic systemic fibrosis (33) 33
magnetic resonance imaging (31) 31
gadobenate dimeglumine (29) 29
gadopentetate dimeglumine (28) 28
gadobutrol (27) 27
contrast media (26) 26
middle aged (26) 26
contrast agents (24) 24
magnetic resonance imaging - methods (22) 22
gadodiamide (21) 21
adult (19) 19
aged (19) 19
contrast media - administration & dosage (19) 19
contrast media - adverse effects (19) 19
dentate nucleus (19) 19
animals (17) 17
globus-pallidus (16) 16
organometallic compounds - administration & dosage (15) 15
organometallic compounds - adverse effects (15) 15
meglumine - administration & dosage (14) 14
gadoterate (13) 13
image enhancement - methods (13) 13
meglumine - adverse effects (13) 13
medicine & public health (12) 12
adolescent (11) 11
aged, 80 and over (11) 11
reproducibility of results (11) 11
sensitivity and specificity (11) 11
brain (10) 10
gadolinium-based contrast agents (10) 10
meglumine - analogs & derivatives (10) 10
rats (10) 10
angiography (9) 9
gadolinium - adverse effects (9) 9
gadoteridol (9) 9
mri (9) 9
organometallic compounds (9) 9
stability (9) 9
chelates (8) 8
comparative analysis (8) 8
contrast media - pharmacokinetics (8) 8
deposition (8) 8
digital-subtraction-angiography (8) 8
imaging / radiology (8) 8
internal medicine (8) 8
nuclear magnetic resonance--nmr (8) 8
original (8) 8
prospective studies (8) 8
child (7) 7
deep cerebellar nuclei (7) 7
diagnostic radiology (7) 7
disease models, animal (7) 7
interventional radiology (7) 7
magnetic resonance angiography (7) 7
magnetic resonance angiography - methods (7) 7
magnetic-resonance angiography (7) 7
media (7) 7
neuroradiology (7) 7
organometallic compounds - pharmacokinetics (7) 7
patients (7) 7
research (7) 7
risk factors (7) 7
safety (7) 7
ultrasound (7) 7
usage (7) 7
3 t (6) 6
92943-93-6 (6) 6
analysis (6) 6
child, preschool (6) 6
dotarem (6) 6
gadofosveset (6) 6
gadoversetamide (6) 6
image quality (6) 6
infant (6) 6
meglumine (6) 6
retrospective studies (6) 6
signal intensity (6) 6
t1-weighted mr-images (6) 6
young adult (6) 6
allergy (5) 5
contrast agent (5) 5
contrast enhancement (5) 5
diagnosis (5) 5
dose-response relationship, drug (5) 5
fibrosis (5) 5
gadolinium dtpa - administration & dosage (5) 5
gadolinium dtpa - pharmacokinetics (5) 5
gadolinium pentetate (5) 5
gadolinium pentetate meglumine (5) 5
gadoterate-meglumine (5) 5
gadoteric acid (5) 5
gadoxetic acid (5) 5
health aspects (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Academic Radiology, ISSN 1076-6332, 10/2019, Volume 26, Issue 10, pp. e284 - e291
Previous studies on possible accumulation of gadolinium-based contrast agents (GBCA) in the brain suggest that macrocyclic GBCA are less likely to accumulate... 
Macrocyclic gadolinium-based contrast agents | Dentate nuclei | Globus pallidus | Gadoterate-meglumine | Multiple sclerosis | Analysis
Journal Article
Journal Article
Journal Article
Journal Article
Investigative Radiology, ISSN 0020-9996, 2017, Volume 52, Issue 7, pp. 396 - 404
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 04/2018, Volume 24, Issue 13, pp. 1486 - 1490
This case highlights a patient with Gilbert syndrome who underwent endoscopic retrograde cholangio-pancreatography (ERCP) with removal of bile duct stones, who... 
Jaundice | Iopromide | Gadoterate meglumine | Gilbert syndrome | Contrast agent | ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY | CHOLESTATIC JAUNDICE | CHOLANGIOGRAPHY | GASTROENTEROLOGY & HEPATOLOGY | Case Report
Journal Article
Journal Article
Acta Radiologica, ISSN 0284-1851, 7/2019, Volume 60, Issue 7, pp. 873 - 879
Background The safety of gadolinium-based contrast agents is a hot topic in radiology. Purpose To evaluate the safety profile of gadobutrol during routine use.... 
Gadobutrol | safety | GADOTERATE MEGLUMINE | HIGH-SIGNAL INTENSITY | GADOPENTETATE DIMEGLUMINE | GLOBUS-PALLIDUS | RESONANCE CONTRAST AGENTS | T1-WEIGHTED MR-IMAGES | DENTATE NUCLEUS | MULTIPLE-SCLEROSIS | CLINICAL SAFETY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NEPHROGENIC SYSTEMIC FIBROSIS | Contrast Agents
Journal Article
European Journal of Radiology, ISSN 0720-048X, 07/2014, Volume 83, Issue 7, pp. 1245 - 1249
To retrospectively compare a reduced dose (RD) (0.075 mmol/kg) of gadobenate dimeglumine (RD-gadobenate) with standard single dose (SSD) (0.1 mmol/kg) of... 
Gadoterate meglumine | Contrast material dose | Brain MRI | Gadobenate dimeglumine | Contrast-enhanced MRI | Magnetic resonance imaging | Analysis
Journal Article